Table of Content

1 Report Overview
1.1 Drug Excipients Definition
1.2 Market by Type
1.2.1 Global Drug Excipients Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Organic Chemicals
1.2.3 Inorganic Chemicals
1.2.4 Others
1.3 Market Segment by Application
1.3.1 Global Drug Excipients Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Solid Drugs
1.3.3 Semisolid Drugs
1.3.4 Liquid Drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Drug Excipients Sales
2.1 Global Drug Excipients Revenue Estimates and Forecasts 2018-2034
2.2 Global Drug Excipients Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Drug Excipients Revenue by Region
2.3.1 Global Drug Excipients Revenue by Region (2018-2023)
2.3.2 Global Drug Excipients Revenue by Region (2024-2034)
2.4 Global Drug Excipients Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Drug Excipients Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Drug Excipients Sales Quantity by Region
2.6.1 Global Drug Excipients Sales Quantity by Region (2018-2023)
2.6.2 Global Drug Excipients Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Drug Excipients Sales Quantity by Manufacturers
3.1.1 Global Drug Excipients Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Drug Excipients Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Drug Excipients Sales in 2024
3.2 Global Drug Excipients Revenue by Manufacturers
3.2.1 Global Drug Excipients Revenue by Manufacturers (2018-2023)
3.2.2 Global Drug Excipients Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Drug Excipients Revenue in 2024
3.3 Global Drug Excipients Sales Price by Manufacturers
3.4 Global Key Players of Drug Excipients, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Drug Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Drug Excipients, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Drug Excipients, Product Offered and Application
3.8 Global Key Manufacturers of Drug Excipients, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Drug Excipients Sales Quantity by Type
4.1.1 Global Drug Excipients Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Drug Excipients Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Drug Excipients Sales Quantity Market Share by Type (2018-2034)
4.2 Global Drug Excipients Revenue by Type
4.2.1 Global Drug Excipients Historical Revenue by Type (2018-2023)
4.2.2 Global Drug Excipients Forecasted Revenue by Type (2024-2034)
4.2.3 Global Drug Excipients Revenue Market Share by Type (2018-2034)
4.3 Global Drug Excipients Price by Type
4.3.1 Global Drug Excipients Price by Type (2018-2023)
4.3.2 Global Drug Excipients Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Drug Excipients Sales Quantity by Application
5.1.1 Global Drug Excipients Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Drug Excipients Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Drug Excipients Sales Quantity Market Share by Application (2018-2034)
5.2 Global Drug Excipients Revenue by Application
5.2.1 Global Drug Excipients Historical Revenue by Application (2018-2023)
5.2.2 Global Drug Excipients Forecasted Revenue by Application (2024-2034)
5.2.3 Global Drug Excipients Revenue Market Share by Application (2018-2034)
5.3 Global Drug Excipients Price by Application
5.3.1 Global Drug Excipients Price by Application (2018-2023)
5.3.2 Global Drug Excipients Price Forecast by Application (2024-2034)
6 North America
6.1 North America Drug Excipients Sales by Company
6.1.1 North America Drug Excipients Revenue by Company (2018-2023)
6.1.2 North America Drug Excipients Sales Quantity by Company (2018-2023)
6.2 North America Drug Excipients Market Size by Type
6.2.1 North America Drug Excipients Sales Quantity by Type (2018-2034)
6.2.2 North America Drug Excipients Revenue by Type (2018-2034)
6.3 North America Drug Excipients Market Size by Application
6.3.1 North America Drug Excipients Sales Quantity by Application (2018-2034)
6.3.2 North America Drug Excipients Revenue by Application (2018-2034)
6.4 North America Drug Excipients Market Size by Country
6.4.1 North America Drug Excipients Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Drug Excipients Revenue by Country (2018-2034)
6.4.3 North America Drug Excipients Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Drug Excipients Sales by Company
7.1.1 Europe Drug Excipients Sales Quantity by Company (2018-2023)
7.1.2 Europe Drug Excipients Revenue by Company (2018-2023)
7.2 Europe Drug Excipients Market Size by Type
7.2.1 Europe Drug Excipients Sales Quantity by Type (2018-2034)
7.2.2 Europe Drug Excipients Revenue by Type (2018-2034)
7.3 Europe Drug Excipients Market Size by Application
7.3.1 Europe Drug Excipients Sales Quantity by Application (2018-2034)
7.3.2 Europe Drug Excipients Revenue by Application (2018-2034)
7.4 Europe Drug Excipients Market Size by Country
7.4.1 Europe Drug Excipients Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Drug Excipients Revenue by Country (2018-2034)
7.4.3 Europe Drug Excipients Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Drug Excipients Sales by Company
8.1.1 China Drug Excipients Sales Quantity by Company (2018-2023)
8.1.2 China Drug Excipients Revenue by Company (2018-2023)
8.2 China Drug Excipients Market Size by Type
8.2.1 China Drug Excipients Sales Quantity by Type (2018-2034)
8.2.2 China Drug Excipients Revenue by Type (2018-2034)
8.3 China Drug Excipients Market Size by Application
8.3.1 China Drug Excipients Sales Quantity by Application (2018-2034)
8.3.2 China Drug Excipients Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Drug Excipients Sales by Company
9.1.1 APAC Drug Excipients Sales Quantity by Company (2018-2023)
9.1.2 APAC Drug Excipients Revenue by Company (2018-2023)
9.2 APAC Drug Excipients Market Size by Type
9.2.1 APAC Drug Excipients Sales Quantity by Type (2018-2034)
9.2.2 APAC Drug Excipients Revenue by Type (2018-2034)
9.3 APAC Drug Excipients Market Size by Application
9.3.1 APAC Drug Excipients Sales Quantity by Application (2018-2034)
9.3.2 APAC Drug Excipients Revenue by Application (2018-2034)
9.4 APAC Drug Excipients Market Size by Region
9.4.1 APAC Drug Excipients Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Drug Excipients Revenue by Region (2018-2034)
9.4.3 APAC Drug Excipients Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Drug Excipients Sales by Company
10.1.1 Middle East, Africa and Latin America Drug Excipients Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Drug Excipients Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Drug Excipients Market Size by Type
10.2.1 Middle East, Africa and Latin America Drug Excipients Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Drug Excipients Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Drug Excipients Market Size by Application
10.3.1 Middle East, Africa and Latin America Drug Excipients Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Drug Excipients Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Drug Excipients Market Size by Country
10.4.1 Middle East, Africa and Latin America Drug Excipients Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Drug Excipients Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Drug Excipients Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Dowdupont
11.1.1 Dowdupont Company Information
11.1.2 Dowdupont Overview
11.1.3 Dowdupont Drug Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Dowdupont Drug Excipients Products and Services
11.1.5 Dowdupont Drug Excipients SWOT Analysis
11.1.6 Dowdupont Recent Developments
11.2 Roquette
11.2.1 Roquette Company Information
11.2.2 Roquette Overview
11.2.3 Roquette Drug Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Roquette Drug Excipients Products and Services
11.2.5 Roquette Drug Excipients SWOT Analysis
11.2.6 Roquette Recent Developments
11.3 Ashland
11.3.1 Ashland Company Information
11.3.2 Ashland Overview
11.3.3 Ashland Drug Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Ashland Drug Excipients Products and Services
11.3.5 Ashland Drug Excipients SWOT Analysis
11.3.6 Ashland Recent Developments
11.4 BASF
11.4.1 BASF Company Information
11.4.2 BASF Overview
11.4.3 BASF Drug Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 BASF Drug Excipients Products and Services
11.4.5 BASF Drug Excipients SWOT Analysis
11.4.6 BASF Recent Developments
11.5 Kerry
11.5.1 Kerry Company Information
11.5.2 Kerry Overview
11.5.3 Kerry Drug Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Kerry Drug Excipients Products and Services
11.5.5 Kerry Drug Excipients SWOT Analysis
11.5.6 Kerry Recent Developments
11.6 Evonik Industries
11.6.1 Evonik Industries Company Information
11.6.2 Evonik Industries Overview
11.6.3 Evonik Industries Drug Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Evonik Industries Drug Excipients Products and Services
11.6.5 Evonik Industries Drug Excipients SWOT Analysis
11.6.6 Evonik Industries Recent Developments
11.7 Croda
11.7.1 Croda Company Information
11.7.2 Croda Overview
11.7.3 Croda Drug Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Croda Drug Excipients Products and Services
11.7.5 Croda Drug Excipients SWOT Analysis
11.7.6 Croda Recent Developments
11.8 Associated British Foods
11.8.1 Associated British Foods Company Information
11.8.2 Associated British Foods Overview
11.8.3 Associated British Foods Drug Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Associated British Foods Drug Excipients Products and Services
11.8.5 Associated British Foods Drug Excipients SWOT Analysis
11.8.6 Associated British Foods Recent Developments
11.9 Archer Daniels Midland
11.9.1 Archer Daniels Midland Company Information
11.9.2 Archer Daniels Midland Overview
11.9.3 Archer Daniels Midland Drug Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Archer Daniels Midland Drug Excipients Products and Services
11.9.5 Archer Daniels Midland Drug Excipients SWOT Analysis
11.9.6 Archer Daniels Midland Recent Developments
11.10 Lubrizol
11.10.1 Lubrizol Company Information
11.10.2 Lubrizol Overview
11.10.3 Lubrizol Drug Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Lubrizol Drug Excipients Products and Services
11.10.5 Lubrizol Drug Excipients SWOT Analysis
11.10.6 Lubrizol Recent Developments
11.11 Innophos Holdings
11.11.1 Innophos Holdings Company Information
11.11.2 Innophos Holdings Overview
11.11.3 Innophos Holdings Drug Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Innophos Holdings Drug Excipients Products and Services
11.11.5 Innophos Holdings Recent Developments
11.12 Wacker Chemie
11.12.1 Wacker Chemie Company Information
11.12.2 Wacker Chemie Overview
11.12.3 Wacker Chemie Drug Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Wacker Chemie Drug Excipients Products and Services
11.12.5 Wacker Chemie Recent Developments
11.13 Signet
11.13.1 Signet Company Information
11.13.2 Signet Overview
11.13.3 Signet Drug Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Signet Drug Excipients Products and Services
11.13.5 Signet Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Drug Excipients Value Chain Analysis
12.2 Drug Excipients Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug Excipients Production Mode & Process
12.4 Drug Excipients Sales and Marketing
12.4.1 Drug Excipients Sales Channels
12.4.2 Drug Excipients Distributors
12.5 Drug Excipients Customers
13 Market Dynamics
13.1 Drug Excipients Industry Trends
13.2 Drug Excipients Market Drivers
13.3 Drug Excipients Market Challenges
13.4 Drug Excipients Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Drug Excipients Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Organic Chemicals
Table 3. Major Manufacturers of Inorganic Chemicals
Table 4. Major Manufacturers of Others
Table 5. Global Drug Excipients Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Drug Excipients Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Drug Excipients Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Drug Excipients Revenue Market Share by Region (2018-2023)
Table 9. Global Drug Excipients Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Drug Excipients Revenue Market Share by Region (2024-2034)
Table 11. Global Drug Excipients Sales Quantity by Region: 2018 VS 2024 VS 2034 (K MT)
Table 12. Global Drug Excipients Sales by Region (2018-2023) & (K MT)
Table 13. Global Drug Excipients Sales Market Share by Region (2018-2023)
Table 14. Global Drug Excipients Sales by Region (2024-2034) & (K MT)
Table 15. Global Drug Excipients Sales Market Share by Region (2024-2034)
Table 16. Global Drug Excipients Sales Quantity by Manufacturers (2018-2023) & (K MT)
Table 17. Global Drug Excipients Sales Quantity Share by Manufacturers (2018-2023)
Table 18. Global Drug Excipients Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Drug Excipients Revenue Share by Manufacturers (2018-2023)
Table 20. Global Drug Excipients Price by Manufacturers 2018-2023 (USD/MT)
Table 21. Global Key Players of Drug Excipients, Industry Ranking, 2021 VS 2024
Table 22. Global Drug Excipients Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Drug Excipients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Excipients as of 2024)
Table 24. Global Key Manufacturers of Drug Excipients, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Drug Excipients, Product Offered and Application
Table 26. Global Key Manufacturers of Drug Excipients, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Drug Excipients Sales Quantity by Type (2018-2023) & (K MT)
Table 29. Global Drug Excipients Sales Quantity by Type (2024-2034) & (K MT)
Table 30. Global Drug Excipients Sales Quantity Share by Type (2018-2023)
Table 31. Global Drug Excipients Sales Quantity Share by Type (2024-2034)
Table 32. Global Drug Excipients Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Drug Excipients Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Drug Excipients Revenue Share by Type (2018-2023)
Table 35. Global Drug Excipients Revenue Share by Type (2024-2034)
Table 36. Drug Excipients Price by Type (2018-2023) & (USD/MT)
Table 37. Global Drug Excipients Price Forecast by Type (2024-2034) & (USD/MT)
Table 38. Global Drug Excipients Sales Quantity by Application (2018-2023) & (K MT)
Table 39. Global Drug Excipients Sales Quantity by Application (2024-2034) & (K MT)
Table 40. Global Drug Excipients Sales Quantity Share by Application (2018-2023)
Table 41. Global Drug Excipients Sales Quantity Share by Application (2024-2034)
Table 42. Global Drug Excipients Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Drug Excipients Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Drug Excipients Revenue Share by Application (2018-2023)
Table 45. Global Drug Excipients Revenue Share by Application (2024-2034)
Table 46. Drug Excipients Price by Application (2018-2023) & (USD/MT)
Table 47. Global Drug Excipients Price Forecast by Application (2024-2034) & (USD/MT)
Table 48. North America Drug Excipients Revenue by Company (2018-2023) & (US$ Million)
Table 49. North America Drug Excipients Sales Quantity by Company (2018-2023) & (K MT)
Table 50. North America Drug Excipients Sales Quantity by Type (2018-2023) & (K MT)
Table 51. North America Drug Excipients Sales Quantity by Type (2024-2034) & (K MT)
Table 52. North America Drug Excipients Revenue by Type (2018-2023) & (US$ Million)
Table 53. North America Drug Excipients Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Drug Excipients Sales Quantity by Application (2018-2023) & (K MT)
Table 55. North America Drug Excipients Sales Quantity by Application (2024-2034) & (K MT)
Table 56. North America Drug Excipients Revenue by Application (2018-2023) & (US$ Million)
Table 57. North America Drug Excipients Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Drug Excipients Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 59. North America Drug Excipients Revenue by Country (2018-2023) & (US$ Million)
Table 60. North America Drug Excipients Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Drug Excipients Sales Quantity by Country (2018-2023) & (K MT)
Table 62. North America Drug Excipients Sales Quantity by Country (2024-2034) & (K MT)
Table 63. Europe Drug Excipients Sales Quantity by Company (2018-2023) & (K MT)
Table 64. Europe Drug Excipients Revenue by Company (2018-2023) & (US$ Million)
Table 65. Europe Drug Excipients Sales Quantity by Type (2018-2023) & (K MT)
Table 66. Europe Drug Excipients Sales Quantity by Type (2024-2034) & (K MT)
Table 67. Europe Drug Excipients Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Drug Excipients Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Drug Excipients Sales Quantity by Application (2018-2023) & (K MT)
Table 70. Europe Drug Excipients Sales Quantity by Application (2024-2034) & (K MT)
Table 71. Europe Drug Excipients Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Drug Excipients Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Drug Excipients Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 74. Europe Drug Excipients Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Drug Excipients Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Drug Excipients Sales Quantity by Country (2018-2023) & (K MT)
Table 77. Europe Drug Excipients Sales Quantity by Country (2024-2034) & (K MT)
Table 78. China Drug Excipients Sales Quantity by Company (2018-2023) & (K MT)
Table 79. China Drug Excipients Revenue by Company (2018-2023) & (US$ Million)
Table 80. China Drug Excipients Sales Quantity by Type (2018-2023) & (K MT)
Table 81. China Drug Excipients Sales Quantity by Type (2024-2034) & (K MT)
Table 82. China Drug Excipients Revenue by Type (2018-2023) & (US$ Million)
Table 83. China Drug Excipients Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Drug Excipients Sales Quantity by Application (2018-2023) & (K MT)
Table 85. China Drug Excipients Sales Quantity by Application (2024-2034) & (K MT)
Table 86. China Drug Excipients Revenue by Application (2018-2023) & (US$ Million)
Table 87. China Drug Excipients Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Drug Excipients Sales Quantity by Company (2018-2023) & (K MT)
Table 89. APAC Drug Excipients Revenue by Company (2018-2023) & (US$ Million)
Table 90. APAC Drug Excipients Sales Quantity by Type (2018-2023) & (K MT)
Table 91. APAC Drug Excipients Sales Quantity by Type (2024-2034) & (K MT)
Table 92. APAC Drug Excipients Revenue by Type (2018-2023) & (US$ Million)
Table 93. APAC Drug Excipients Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Drug Excipients Sales Quantity by Application (2018-2023) & (K MT)
Table 95. APAC Drug Excipients Sales Quantity by Application (2024-2034) & (K MT)
Table 96. APAC Drug Excipients Revenue by Application (2018-2023) & (US$ Million)
Table 97. APAC Drug Excipients Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Drug Excipients Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 99. APAC Drug Excipients Revenue by Region (2018-2023) & (US$ Million)
Table 100. APAC Drug Excipients Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Drug Excipients Sales Quantity by Region (2018-2023) & (K MT)
Table 102. APAC Drug Excipients Sales Quantity by Region (2024-2034) & (K MT)
Table 103. Middle East, Africa and Latin America Drug Excipients Sales Quantity by Company (2018-2023) & (K MT)
Table 104. Middle East, Africa and Latin America Drug Excipients Revenue by Company (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Drug Excipients Sales Quantity by Type (2018-2023) & (K MT)
Table 106. Middle East, Africa and Latin America Drug Excipients Sales Quantity by Type (2024-2034) & (K MT)
Table 107. Middle East, Africa and Latin America Drug Excipients Revenue by Type (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Drug Excipients Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Drug Excipients Sales Quantity by Application (2018-2023) & (K MT)
Table 110. Middle East, Africa and Latin America Drug Excipients Sales Quantity by Application (2024-2034) & (K MT)
Table 111. Middle East, Africa and Latin America Drug Excipients Revenue by Application (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Drug Excipients Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Drug Excipients Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Drug Excipients Revenue by Country (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Drug Excipients Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Drug Excipients Sales Quantity by Country (2018-2023) & (K MT)
Table 117. Middle East, Africa and Latin America Drug Excipients Sales Quantity by Country (2024-2034) & (K MT)
Table 118. Dowdupont Company Information
Table 119. Dowdupont Description and Overview
Table 120. Dowdupont Drug Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 121. Dowdupont Drug Excipients Product and Services
Table 122. Dowdupont Drug Excipients SWOT Analysis
Table 123. Dowdupont Recent Developments
Table 124. Roquette Company Information
Table 125. Roquette Description and Overview
Table 126. Roquette Drug Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 127. Roquette Drug Excipients Product and Services
Table 128. Roquette Drug Excipients SWOT Analysis
Table 129. Roquette Recent Developments
Table 130. Ashland Company Information
Table 131. Ashland Description and Overview
Table 132. Ashland Drug Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 133. Ashland Drug Excipients Product and Services
Table 134. Ashland Drug Excipients SWOT Analysis
Table 135. Ashland Recent Developments
Table 136. BASF Company Information
Table 137. BASF Description and Overview
Table 138. BASF Drug Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 139. BASF Drug Excipients Product and Services
Table 140. BASF Drug Excipients SWOT Analysis
Table 141. BASF Recent Developments
Table 142. Kerry Company Information
Table 143. Kerry Description and Overview
Table 144. Kerry Drug Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 145. Kerry Drug Excipients Product and Services
Table 146. Kerry Drug Excipients SWOT Analysis
Table 147. Kerry Recent Developments
Table 148. Evonik Industries Company Information
Table 149. Evonik Industries Description and Overview
Table 150. Evonik Industries Drug Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 151. Evonik Industries Drug Excipients Product and Services
Table 152. Evonik Industries Drug Excipients SWOT Analysis
Table 153. Evonik Industries Recent Developments
Table 154. Croda Company Information
Table 155. Croda Description and Overview
Table 156. Croda Drug Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 157. Croda Drug Excipients Product and Services
Table 158. Croda Drug Excipients SWOT Analysis
Table 159. Croda Recent Developments
Table 160. Associated British Foods Company Information
Table 161. Associated British Foods Description and Overview
Table 162. Associated British Foods Drug Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 163. Associated British Foods Drug Excipients Product and Services
Table 164. Associated British Foods Drug Excipients SWOT Analysis
Table 165. Associated British Foods Recent Developments
Table 166. Archer Daniels Midland Company Information
Table 167. Archer Daniels Midland Description and Overview
Table 168. Archer Daniels Midland Drug Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 169. Archer Daniels Midland Drug Excipients Product and Services
Table 170. Archer Daniels Midland Drug Excipients SWOT Analysis
Table 171. Archer Daniels Midland Recent Developments
Table 172. Lubrizol Company Information
Table 173. Lubrizol Description and Overview
Table 174. Lubrizol Drug Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 175. Lubrizol Drug Excipients Product and Services
Table 176. Lubrizol Drug Excipients SWOT Analysis
Table 177. Lubrizol Recent Developments
Table 178. Innophos Holdings Company Information
Table 179. Innophos Holdings Description and Overview
Table 180. Innophos Holdings Drug Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 181. Innophos Holdings Drug Excipients Product and Services
Table 182. Innophos Holdings Recent Developments
Table 183. Wacker Chemie Company Information
Table 184. Wacker Chemie Description and Overview
Table 185. Wacker Chemie Drug Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 186. Wacker Chemie Drug Excipients Product and Services
Table 187. Wacker Chemie Recent Developments
Table 188. Signet Company Information
Table 189. Signet Description and Overview
Table 190. Signet Drug Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 191. Signet Drug Excipients Product and Services
Table 192. Signet Recent Developments
Table 193. Key Raw Materials Lists
Table 194. Raw Materials Key Suppliers Lists
Table 195. Drug Excipients Distributors List
Table 196. Drug Excipients Customers List
Table 197. Drug Excipients Market Trends
Table 198. Drug Excipients Market Drivers
Table 199. Drug Excipients Market Challenges
Table 200. Drug Excipients Market Restraints
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Excipients Product Picture
Figure 2. Global Drug Excipients Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Drug Excipients Market Share by Type in 2024 & 2034
Figure 4. Organic Chemicals Product Picture
Figure 5. Inorganic Chemicals Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drug Excipients Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 8. Global Drug Excipients Market Share by Application in 2024 & 2034
Figure 9. Solid Drugs
Figure 10. Semisolid Drugs
Figure 11. Liquid Drugs
Figure 12. Drug Excipients Report Years Considered
Figure 13. Global Drug Excipients Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Drug Excipients Revenue 2018-2034 (US$ Million)
Figure 15. Global Drug Excipients Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 16. Global Drug Excipients Sales Quantity 2018-2034 (K MT)
Figure 17. Global Drug Excipients Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Drug Excipients Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Drug Excipients Sales Quantity YoY (2018-2034) & (K MT)
Figure 20. North America Drug Excipients Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Drug Excipients Sales Quantity YoY (2018-2034) & (K MT)
Figure 22. Europe Drug Excipients Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Drug Excipients Sales Quantity YoY (2018-2034) & (K MT)
Figure 24. China Drug Excipients Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Drug Excipients Sales Quantity YoY (2018-2034) & (K MT)
Figure 26. APAC Drug Excipients Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Drug Excipients Sales Quantity YoY (2018-2034) & (K MT)
Figure 28. Middle East, Africa and Latin America Drug Excipients Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Drug Excipients Sales Quantity in 2024
Figure 30. The Top 10 and Top 5 Players Market Share by Drug Excipients Revenue in 2024
Figure 31. Drug Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 32. Global Drug Excipients Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Drug Excipients Revenue Market Share by Type (2018-2034)
Figure 34. Global Drug Excipients Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Drug Excipients Revenue Market Share by Application (2018-2034)
Figure 36. North America Drug Excipients Revenue Market Share by Company in 2024
Figure 37. North America Drug Excipients Sales Quantity Market Share by Company in 2024
Figure 38. North America Drug Excipients Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Drug Excipients Revenue Market Share by Type (2018-2034)
Figure 40. North America Drug Excipients Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Drug Excipients Revenue Market Share by Application (2018-2034)
Figure 42. North America Drug Excipients Revenue Share by Country (2018-2034)
Figure 43. North America Drug Excipients Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Drug Excipients Sales Quantity Market Share by Company in 2024
Figure 47. Europe Drug Excipients Revenue Market Share by Company in 2024
Figure 48. Europe Drug Excipients Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Drug Excipients Revenue Market Share by Type (2018-2034)
Figure 50. Europe Drug Excipients Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Drug Excipients Revenue Market Share by Application (2018-2034)
Figure 52. Europe Drug Excipients Revenue Share by Country (2018-2034)
Figure 53. Europe Drug Excipients Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 55. France Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 59. China Drug Excipients Sales Quantity Market Share by Company in 2024
Figure 60. China Drug Excipients Revenue Market Share by Company in 2024
Figure 61. China Drug Excipients Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Drug Excipients Revenue Market Share by Type (2018-2034)
Figure 63. China Drug Excipients Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Drug Excipients Revenue Market Share by Application (2018-2034)
Figure 65. APAC Drug Excipients Sales Quantity Market Share by Company in 2024
Figure 66. APAC Drug Excipients Revenue Market Share by Company in 2024
Figure 67. APAC Drug Excipients Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Drug Excipients Revenue Market Share by Type (2018-2034)
Figure 69. APAC Drug Excipients Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Drug Excipients Revenue Market Share by Application (2018-2034)
Figure 71. APAC Drug Excipients Revenue Share by Region (2018-2034)
Figure 72. APAC Drug Excipients Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 77. India Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Drug Excipients Sales Quantity Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Drug Excipients Revenue Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Drug Excipients Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Drug Excipients Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Drug Excipients Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Drug Excipients Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Drug Excipients Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Drug Excipients Revenue Share by Country (2018-2034)
Figure 86. Brazil Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Drug Excipients Revenue (2018-2034) & (US$ Million)
Figure 91. Drug Excipients Value Chain
Figure 92. Drug Excipients Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed